- Patent’s Defeat in India Is Key Victory for Generic Drugs: India’s top court rejected a Swiss drug maker’s patent request for a major cancer drug on Monday, ensuring poor patients’ access to many of the world’s best drugs, at least for a while http://www.nytimes.com/2013/04/02/business/global/top-court-in-india-rejects-novartis-drug-patent.html/ 38 comments worldnews
- Indian Supreme Court rejects Novartis' patent petition, allowing a price drop on leukemia medicine around the world. From $70,000 to $2,500. http://www.nytimes.com/2013/04/02/business/global/top-court-in-india-rejects-novartis-drug-patent.html 35 comments worldnews
Linked pages
- India Orders Bayer to License Patented Cancer Drug - The New York Times http://www.nytimes.com/2012/03/13/business/global/india-overrules-bayer-allowing-generic-drug.html?_r=1&adxnnl=1&adxnnlx=1331578809-OC1gj5v7vMffNnNY0dydMA&seid=auto&smid=tw-nytimes 107 comments
- Rahul Gandhi, Leader of India’s Opposition to Modi, Disqualified From Parliament - The New York Times https://www.nytimes.com/2023/03/24/world/asia/india-gandhi-modi.html?smid=tw-nytimes&smtyp=cur 25 comments
- Modi Tightens Grip on India’s Democracy, Wielding the Judiciary - The New York Times https://www.nytimes.com/2023/03/29/world/asia/modi-india-gandhi-judiciary.html 14 comments
- India Is Arming Villagers in Jammu and Kashmir - The New York Times https://www.nytimes.com/2023/03/08/world/asia/kashmir-village-defense-committees.html?campaign_id=7&emc=edit_mbae_20230309&instance_id=87177&nl=morning-briefing%3A-asia-pacific-edition®i_id=203298882&segment_id=127223&te=1&user_id=a5001a41f043a883acc248e4f43d4624 3 comments
Related searches:
Search whole site: site:nytimes.com
Search title: Top Court in India Rejects Novartis Drug Patent - The New York Times
See how to search.